Authors: Rassmann, I Thodtmann, R Mross, M Huttmann, A Berdel, WE Manegold, C Fiebig, HH Kaeser-Frohlich, A Burk, K Hanauske, AR

Citation: I. Rassmann et al., Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion, INV NEW DR, 16(4), 1998, pp. 319-324